| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |